Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ADH1B | P00325 | 2/20 | 0.39 |
| ▸ | ADH1C | P00326 | 2/20 | 0.39 |
| ▸ | ADH1A | P07327 | 2/20 | 0.39 |
| ▸ | METAP2 | P50579 | 8/20 | 0.38 |
| ▸ | METAP1 | P53582 | 6/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5527208 | 1.00 | MGAM (0.41) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL23044882 | 0.83 | HCAR2 (0.38) | ALDH1A1ADH1BADH1CADH1ANPSR1 | |
| SCHEMBL11026074 | 0.83 | HCAR2 (0.38) | ALDH1A1ADH1BADH1CADH1ANPSR1 | |
| SCHEMBL14412682 | 0.83 | ADH1B (0.39) | ADH1BADH1CADH1ACNR1DAGLA | |
| SCHEMBL11508858 | 0.83 | MGAM (0.41) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL11511632 | 0.83 | MGAM (0.41) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL11027872 | 0.81 | TSHR (0.45) | ALDH1A1ADH1BADH1CADH1AHSD17B10 | |
| SCHEMBL17287125 | 0.80 | ATM (0.47) | ALDH1A1ADH1BADH1CADH1ANPSR1 | |
| SCHEMBL6826472 | 0.80 | ATM (0.47) | ALDH1A1ADH1BADH1CADH1ANPSR1 | |
| SCHEMBL6826471 | 0.80 | ATM (0.47) | ALDH1A1ADH1BADH1CADH1ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112694450-B | Preparation method of 4-methyl-5-ethoxy oxazole | 浙江圣达生物药业股份有限公司 | 2022-06-21 | — | — | CN | claimed |
| WO-2021037022-A1 | METHOD FOR PREPARING 4-METHYL-5-ALKOXY OXAZOLE | 山东新和成精化科技有限公司 | 2021-03-04 | — | — | WO | claimed |
| CN-110423226-B | Preparation method of 4-methyl-5-alkoxy oxazole | 山东新和成精化科技有限公司 | 2021-01-05 | — | — | CN | claimed |
| CN-114702405-A | Preparation method of N-ethoxy oxalyl alanine ethyl ester | 浙江花园营养科技有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-114671823-A | Preparation method of 4-methyl-5-ethoxy oxazole acid ethyl ester | 浙江花园营养科技有限公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-112694450-B | Preparation method of 4-methyl-5-ethoxy oxazole | 浙江圣达生物药业股份有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-112694450-B | Preparation method of 4-methyl-5-ethoxy oxazole | 浙江圣达生物药业股份有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-112694450-A | Preparation method of 4-methyl-5-ethoxy oxazole | 浙江圣达生物药业股份有限公司 | 2021-04-23 | — | — | CN | disclosed |
| WO-2021037022-A1 | METHOD FOR PREPARING 4-METHYL-5-ALKOXY OXAZOLE | 山东新和成精化科技有限公司 | 2021-03-04 | — | — | WO | disclosed |
| CN-110423226-B | Preparation method of 4-methyl-5-alkoxy oxazole | 山东新和成精化科技有限公司 | 2021-01-05 | — | — | CN | disclosed |
| US-9796641-B2 | Stabilization of radiosynthetic intermediates | TRASIS S.A. (BE) | 2017-10-24 | — | — | US | disclosed |
| WO-2009105513-A2 | NOVEL COMPOUNDS AND METHODS FOR THERAPY | GILEAD SCIENCES, INC. (US) | 2009-08-27 | — | — | WO | disclosed |
| US-20030100790-A1 | Process for preparing N-formylamino carboxylic esters | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-29 | — | — | US | disclosed |
| EP-1310481-A1 | Process for the preparation of N-formyl-aminocarboxylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-14 | — | — | EP | disclosed |
| EP-0080119-B1 | PROCESS FOR THE PREPARATION OF N-FORMYL-ALPHA-AMINO-ACID ESTERS | BASF Aktiengesellschaft (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0080119-A1 | Process for the preparation of N-formyl-alpha-amino-acid esters | BASF Aktiengesellschaft (DE) | 1983-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100790-A1 | Process for preparing N-formylamino carboxylic esters | DNPEP, QPCT, FPR3 | MGAM 928/4885GAA 2621/4885SI 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.